Literature DB >> 25561363

c-Abl induces stabilization of histone deacetylase 1 (HDAC1) in a kinase activity-dependent manner.

Kazumasa Aoyama1, Noritaka Yamaguchi, Ryuzaburo Yuki, Mariko Morii, Sho Kubota, Kensuke Hirata, Kohei Abe, Takuya Honda, Takahisa Kuga, Yuuki Hashimoto, Takeshi Tomonaga, Naoto Yamaguchi.   

Abstract

c-Abl is a non-receptor-type tyrosine kinase that regulates various cellular events, including cell proliferation, differentiation, and apoptosis, through phosphorylation of cytoplasmic and nuclear targets. Although we showed that c-Abl induces histone deacetylation, the molecular mechanisms of this phenomenon are largely unknown. Here, we analyzed the effect of c-Abl on the expression of histone deacetylase 1 (HDAC1), because c-Abl was shown to be involved in maintenance of nuclear protein levels of HDAC1. Co-transfection of HDAC1 with c-Abl increased the levels of HDAC1 protein in a kinase activity-dependent manner without affecting its mRNA levels. Treatment with the proteasome inhibitor MG132 increased protein levels of HDAC1 in cells transfected with HDAC1 but not in cells co-transfected with HDAC1 and c-Abl. Among class I HDACs, knockdown of endogenous c-Abl preferentially suppressed endogenous protein levels of HDAC1, suggesting that c-Abl stabilizes HDAC1 protein by inhibiting its proteasomal degradation. Subcellular fractionation showed that the stabilization of HDAC1 by c-Abl occurred in the nucleus. Despite the fact that HDAC1 was phosphorylated by co-expression with c-Abl, stabilization of HDAC1 by c-Abl was not affected by mutations in its sites phosphorylated by c-Abl. Co-expression with HDAC1 and nuclear-targeted c-Abl did not affect HDAC1 stabilization. Therefore, these results suggest that c-Abl induces HDAC1 stabilization possibly through phosphorylation of a cytoplasmic target that is involved in proteasomal degradation of HDAC1.
© 2015 International Federation for Cell Biology.

Entities:  

Keywords:  c-Abl tyrosine kinase; histone deacetylase; protein stability

Mesh:

Substances:

Year:  2015        PMID: 25561363     DOI: 10.1002/cbin.10413

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  7 in total

1.  Src Acts as an Effector for Ku70-dependent Suppression of Apoptosis through Phosphorylation of Ku70 at Tyr-530.

Authors:  Mariko Morii; Sho Kubota; Takuya Honda; Ryuzaburo Yuki; Takao Morinaga; Takahisa Kuga; Takeshi Tomonaga; Noritaka Yamaguchi; Naoto Yamaguchi
Journal:  J Biol Chem       Date:  2016-12-20       Impact factor: 5.157

2.  Desuppression of TGF-β signaling via nuclear c-Abl-mediated phosphorylation of TIF1γ/TRIM33 at Tyr-524, -610, and -1048.

Authors:  Ryuzaburo Yuki; Takashi Tatewaki; Noritaka Yamaguchi; Kazumasa Aoyama; Takuya Honda; Sho Kubota; Mariko Morii; Ichiro Manabe; Takahisa Kuga; Takeshi Tomonaga; Naoto Yamaguchi
Journal:  Oncogene       Date:  2018-09-03       Impact factor: 9.867

3.  Role for Tyrosine Phosphorylation of A-kinase Anchoring Protein 8 (AKAP8) in Its Dissociation from Chromatin and the Nuclear Matrix.

Authors:  Sho Kubota; Mariko Morii; Ryuzaburo Yuki; Noritaka Yamaguchi; Hiromi Yamaguchi; Kazumasa Aoyama; Takahisa Kuga; Takeshi Tomonaga; Naoto Yamaguchi
Journal:  J Biol Chem       Date:  2015-03-13       Impact factor: 5.157

4.  Neuronal gene repression in Niemann-Pick type C models is mediated by the c-Abl/HDAC2 signaling pathway.

Authors:  Pablo S Contreras; Marcelo Gonzalez-Zuñiga; Lila González-Hódar; María José Yáñez; Andrés Dulcey; Juan Marugan; Edward Seto; Alejandra R Alvarez; Silvana Zanlungo
Journal:  Biochim Biophys Acta       Date:  2015-11-19

5.  c-Abl-TWIST1 Epigenetically Dysregulate Inflammatory Responses during Mycobacterial Infection by Co-Regulating Bone Morphogenesis Protein and miR27a.

Authors:  Kasturi Mahadik; Praveen Prakhar; R S Rajmani; Amit Singh; Kithiganahalli Narayanaswamy Balaji
Journal:  Front Immunol       Date:  2018-02-01       Impact factor: 7.561

Review 6.  c-Abl kinase at the crossroads of healthy synaptic remodeling and synaptic dysfunction in neurodegenerative diseases.

Authors:  Daniela A Gutiérrez; América Chandía-Cristi; María José Yáñez; Silvana Zanlungo; Alejandra R Álvarez
Journal:  Neural Regen Res       Date:  2023-02       Impact factor: 6.058

7.  Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation.

Authors:  Adnan Erol
Journal:  Cancer Manag Res       Date:  2022-08-05       Impact factor: 3.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.